Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke

NCT04097652 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

BIOLOGICAL: UMC119-06

Sponsor

Meridigen Biotech Co., Ltd.